Furthermore, both SARS-CoV-2 and elevated GFAP were reportedly detectable in the CSF of a COVID-19 patient nearly three weeks after symptom onset and after having tested negative twice for the virus [92]. The gene discussed is GFAP; the disease is COVID-19.